OP107 Streamlining Health Technology Assessment Of Medical Devices Through Development Of The Philippine Essential Medical Device List

IF 2.6 4区 医学 Q2 HEALTH CARE SCIENCES & SERVICES International Journal of Technology Assessment in Health Care Pub Date : 2023-12-14 DOI:10.1017/s0266462323001198
Patrick Wincy Reyes, Lara Alyssa Liban, Ma. Cecilia Victoria Arellano, Joshua Santillan, Sheena Jasley Samonte, Anne Julienne Marfori, Anna Melissa Guerrero, Marc James delos Santos, Catherine Manuela Lee-Ramos, Agnette Peralta, Department of Health – Medical Device Unit, Health Technology Assessment Council
{"title":"OP107 Streamlining Health Technology Assessment Of Medical Devices Through Development Of The Philippine Essential Medical Device List","authors":"Patrick Wincy Reyes, Lara Alyssa Liban, Ma. Cecilia Victoria Arellano, Joshua Santillan, Sheena Jasley Samonte, Anne Julienne Marfori, Anna Melissa Guerrero, Marc James delos Santos, Catherine Manuela Lee-Ramos, Agnette Peralta, Department of Health – Medical Device Unit, Health Technology Assessment Council","doi":"10.1017/s0266462323001198","DOIUrl":null,"url":null,"abstract":"<span>Introduction</span><p>Pursuant to the Universal Health Care Act of 2019, the Health Technology Assessment Council (HTAC) in the Philippines was mandated to make recommendations for government financing of health technologies, including medical devices. The development of a Philippine Essential Medical Device List (PEMDL) will serve as a guide for the procurement of medical devices and supplies in government health facilities and as the basis for creating a price reference index.</p><span>Methods</span><p>The HTAC and a team of medical device experts (the Expert Advisory Committee) developed a streamlined pathway and guidelines using a Delphi technique with the Philippine Food and Drug Administration (FDA) and the Department of Health (DOH) to determine the necessary criteria for fast tracking the inclusion of medical devices. The pathway was also revised throughout a pilot processing of commonly procured medical devices (e.g., consumables) that were either already covered by existing national health insurance packages or funded by DOH programs, among others.</p><span>Results</span><p>The final pathway consisted of validating whether the device was already approved by the Philippine FDA and whether it was already part of standard of care. Similar to the usual HTA nomination requirement, the local FDA approval attested to the safety and quality of the device. Meanwhile, the inclusion of the device in the standard of care guaranteed that it was essential in the healthcare setting. This can be written in the World Health Organization technical documents and databases such as the Medical Devices Information System, health facility listing requirements, or locally adopted clinical practice guidelines. The initial PEMDL for release contained a total of 307 medical devices across 16 categories.</p><span>Conclusions</span><p>Unlike the mandate for the Philippine National Formulary, government health facilities are not yet required to base their procurement on the PEMDL because the list is still in its infancy. Moving forward, the list will include big ticket items and will be updated through consultations with specialty centers and hospitals.</p>","PeriodicalId":14467,"journal":{"name":"International Journal of Technology Assessment in Health Care","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Technology Assessment in Health Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/s0266462323001198","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Pursuant to the Universal Health Care Act of 2019, the Health Technology Assessment Council (HTAC) in the Philippines was mandated to make recommendations for government financing of health technologies, including medical devices. The development of a Philippine Essential Medical Device List (PEMDL) will serve as a guide for the procurement of medical devices and supplies in government health facilities and as the basis for creating a price reference index.

Methods

The HTAC and a team of medical device experts (the Expert Advisory Committee) developed a streamlined pathway and guidelines using a Delphi technique with the Philippine Food and Drug Administration (FDA) and the Department of Health (DOH) to determine the necessary criteria for fast tracking the inclusion of medical devices. The pathway was also revised throughout a pilot processing of commonly procured medical devices (e.g., consumables) that were either already covered by existing national health insurance packages or funded by DOH programs, among others.

Results

The final pathway consisted of validating whether the device was already approved by the Philippine FDA and whether it was already part of standard of care. Similar to the usual HTA nomination requirement, the local FDA approval attested to the safety and quality of the device. Meanwhile, the inclusion of the device in the standard of care guaranteed that it was essential in the healthcare setting. This can be written in the World Health Organization technical documents and databases such as the Medical Devices Information System, health facility listing requirements, or locally adopted clinical practice guidelines. The initial PEMDL for release contained a total of 307 medical devices across 16 categories.

Conclusions

Unlike the mandate for the Philippine National Formulary, government health facilities are not yet required to base their procurement on the PEMDL because the list is still in its infancy. Moving forward, the list will include big ticket items and will be updated through consultations with specialty centers and hospitals.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
OP107 通过制定菲律宾基本医疗设备清单简化医疗设备的卫生技术评估
导言根据 2019 年《全民医疗保健法》,菲律宾卫生技术评估委员会(HTAC)的任务是就政府对医疗技术(包括医疗器械)的资助提出建议。菲律宾基本医疗器械清单(PEMDL)的制定将作为政府卫生机构采购医疗器械和用品的指南,并作为创建价格参考指数的基础。方法菲律宾卫生技术评估委员会和医疗器械专家团队(专家咨询委员会)采用德尔菲技术,与菲律宾食品药品管理局(FDA)和卫生部(DOH)共同制定了简化路径和指南,以确定快速纳入医疗器械的必要标准。结果最终的路径包括验证设备是否已经获得菲律宾 FDA 的批准,以及是否已经成为医疗标准的一部分。与通常的 HTA 提名要求类似,当地 FDA 的批准证明了设备的安全性和质量。与此同时,将该设备纳入医疗标准则保证了它在医疗环境中的重要性。这可以写入世界卫生组织的技术文件和数据库(如医疗器械信息系统)、医疗机构列表要求或当地采用的临床实践指南。结论 与《菲律宾国家处方集》的规定不同,政府卫生机构尚未被要求根据《菲律宾国家处方集》进行采购,因为该清单仍处于起步阶段。今后,该清单将包括大型项目,并将通过与专科中心和医院的协商进行更新。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Journal of Technology Assessment in Health Care
International Journal of Technology Assessment in Health Care 医学-公共卫生、环境卫生与职业卫生
CiteScore
4.40
自引率
15.60%
发文量
116
审稿时长
6-12 weeks
期刊介绍: International Journal of Technology Assessment in Health Care serves as a forum for the wide range of health policy makers and professionals interested in the economic, social, ethical, medical and public health implications of health technology. It covers the development, evaluation, diffusion and use of health technology, as well as its impact on the organization and management of health care systems and public health. In addition to general essays and research reports, regular columns on technology assessment reports and thematic sections are published.
期刊最新文献
Development of an MCDA Framework for Rare Disease Reimbursement Prioritization in Malaysia. Experiences of patient organizations' involvement in medicine appraisal and reimbursement processes in Finland - a qualitative study. PP78 Real-World Trends And Medical Costs Of Stroke After Transcatheter Aortic Valve Implantation In Korea: A Nationwide, Population-Based Study Can requests for real-world evidence by the French HTA body be planned? An exhaustive retrospective case-control study of medicinal products appraisals from 2016 to 2021. A systematic review of the cost and cost-effectiveness of immunoglobulin treatment in patients with hematological malignancies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1